nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Methotrexate—stomach cancer	0.31	1	CrCtD
Pralatrexate—TYMS—stomach cancer	0.143	1	CbGaD
Pralatrexate—TYMS—Floxuridine—stomach cancer	0.11	0.409	CbGbCtD
Pralatrexate—SLC19A1—Methotrexate—stomach cancer	0.0441	0.165	CbGbCtD
Pralatrexate—Tetrahydrofolic acid—Methotrexate—stomach cancer	0.041	0.2	CrCrCtD
Pralatrexate—Folic Acid—Methotrexate—stomach cancer	0.041	0.2	CrCrCtD
Pralatrexate—Leucovorin—Methotrexate—stomach cancer	0.041	0.2	CrCrCtD
Pralatrexate—Pemetrexed—Methotrexate—stomach cancer	0.041	0.2	CrCrCtD
Pralatrexate—Raltitrexed—Methotrexate—stomach cancer	0.041	0.2	CrCrCtD
Pralatrexate—TYMS—Capecitabine—stomach cancer	0.0345	0.129	CbGbCtD
Pralatrexate—FPGS—Methotrexate—stomach cancer	0.0319	0.119	CbGbCtD
Pralatrexate—TYMS—Fluorouracil—stomach cancer	0.0205	0.0763	CbGbCtD
Pralatrexate—DHFR—Methotrexate—stomach cancer	0.0162	0.0604	CbGbCtD
Pralatrexate—TYMS—Methotrexate—stomach cancer	0.0113	0.0421	CbGbCtD
Pralatrexate—Renal failure chronic—Mitomycin—stomach cancer	0.00206	0.0832	CcSEcCtD
Pralatrexate—SLC19A1—hematopoietic system—stomach cancer	0.0013	0.0925	CbGeAlD
Pralatrexate—SLC19A1—lymphoid tissue—stomach cancer	0.000917	0.0652	CbGeAlD
Pralatrexate—SLC19A1—digestive system—stomach cancer	0.000906	0.0644	CbGeAlD
Pralatrexate—Tumour lysis syndrome—Irinotecan—stomach cancer	0.00087	0.035	CcSEcCtD
Pralatrexate—FPGS—hematopoietic system—stomach cancer	0.000868	0.0617	CbGeAlD
Pralatrexate—SLC19A1—endocrine gland—stomach cancer	0.000749	0.0532	CbGeAlD
Pralatrexate—SLC19A1—liver—stomach cancer	0.000675	0.0479	CbGeAlD
Pralatrexate—TYMS—Paclitaxel—Docetaxel—stomach cancer	0.000638	1	CbGdCrCtD
Pralatrexate—FPGS—lymphoid tissue—stomach cancer	0.000611	0.0434	CbGeAlD
Pralatrexate—FPGS—digestive system—stomach cancer	0.000604	0.0429	CbGeAlD
Pralatrexate—TYMS—hematopoietic system—stomach cancer	0.000569	0.0404	CbGeAlD
Pralatrexate—DHFR—hematopoietic system—stomach cancer	0.000564	0.04	CbGeAlD
Pralatrexate—SLC19A1—lymph node—stomach cancer	0.000517	0.0368	CbGeAlD
Pralatrexate—TYMS—smooth muscle tissue—stomach cancer	0.000501	0.0356	CbGeAlD
Pralatrexate—FPGS—endocrine gland—stomach cancer	0.000499	0.0354	CbGeAlD
Pralatrexate—FPGS—liver—stomach cancer	0.00045	0.0319	CbGeAlD
Pralatrexate—Tumour lysis syndrome—Methotrexate—stomach cancer	0.000433	0.0175	CcSEcCtD
Pralatrexate—Pancytopenia—Floxuridine—stomach cancer	0.000422	0.017	CcSEcCtD
Pralatrexate—Tumour lysis syndrome—Epirubicin—stomach cancer	0.000405	0.0163	CcSEcCtD
Pralatrexate—TYMS—lymphoid tissue—stomach cancer	0.000401	0.0285	CbGeAlD
Pralatrexate—DHFR—lymphoid tissue—stomach cancer	0.000397	0.0282	CbGeAlD
Pralatrexate—TYMS—digestive system—stomach cancer	0.000396	0.0281	CbGeAlD
Pralatrexate—DHFR—digestive system—stomach cancer	0.000392	0.0278	CbGeAlD
Pralatrexate—Tumour lysis syndrome—Doxorubicin—stomach cancer	0.000375	0.0151	CcSEcCtD
Pralatrexate—Epistaxis—Floxuridine—stomach cancer	0.000374	0.0151	CcSEcCtD
Pralatrexate—TYMS—bone marrow—stomach cancer	0.000365	0.0259	CbGeAlD
Pralatrexate—Raltitrexed—TYMS—stomach cancer	0.000363	0.261	CrCbGaD
Pralatrexate—DHFR—bone marrow—stomach cancer	0.000361	0.0257	CbGeAlD
Pralatrexate—FPGS—lymph node—stomach cancer	0.000345	0.0245	CbGeAlD
Pralatrexate—Pancytopenia—Mitomycin—stomach cancer	0.000331	0.0133	CcSEcCtD
Pralatrexate—TYMS—endocrine gland—stomach cancer	0.000327	0.0232	CbGeAlD
Pralatrexate—DHFR—endocrine gland—stomach cancer	0.000324	0.023	CbGeAlD
Pralatrexate—Night sweats—Capecitabine—stomach cancer	0.000299	0.0121	CcSEcCtD
Pralatrexate—TYMS—liver—stomach cancer	0.000295	0.021	CbGeAlD
Pralatrexate—DHFR—liver—stomach cancer	0.000292	0.0207	CbGeAlD
Pralatrexate—Anaemia—Floxuridine—stomach cancer	0.000286	0.0115	CcSEcCtD
Pralatrexate—Neoplasm malignant—Irinotecan—stomach cancer	0.000283	0.0114	CcSEcCtD
Pralatrexate—Leukopenia—Floxuridine—stomach cancer	0.000277	0.0112	CcSEcCtD
Pralatrexate—Leucovorin—TYMS—stomach cancer	0.000275	0.198	CrCbGaD
Pralatrexate—Thrombocytopenia—Floxuridine—stomach cancer	0.000247	0.00997	CcSEcCtD
Pralatrexate—Pharyngolaryngeal pain—Docetaxel—stomach cancer	0.000247	0.00996	CcSEcCtD
Pralatrexate—Laryngeal pain—Docetaxel—stomach cancer	0.000245	0.00987	CcSEcCtD
Pralatrexate—Anorexia—Floxuridine—stomach cancer	0.000241	0.00971	CcSEcCtD
Pralatrexate—Pharyngolaryngeal pain—Capecitabine—stomach cancer	0.000239	0.00964	CcSEcCtD
Pralatrexate—Laryngeal pain—Capecitabine—stomach cancer	0.000237	0.00955	CcSEcCtD
Pralatrexate—TYMS—lymph node—stomach cancer	0.000226	0.0161	CbGeAlD
Pralatrexate—Anaemia—Mitomycin—stomach cancer	0.000225	0.00905	CcSEcCtD
Pralatrexate—DHFR—lymph node—stomach cancer	0.000224	0.0159	CbGeAlD
Pralatrexate—Pemetrexed—TYMS—stomach cancer	0.00022	0.158	CrCbGaD
Pralatrexate—Decreased appetite—Floxuridine—stomach cancer	0.00022	0.00885	CcSEcCtD
Pralatrexate—Leukopenia—Mitomycin—stomach cancer	0.000217	0.00876	CcSEcCtD
Pralatrexate—Cough—Mitomycin—stomach cancer	0.000212	0.00854	CcSEcCtD
Pralatrexate—Sepsis—Irinotecan—stomach cancer	0.000209	0.00844	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Floxuridine—stomach cancer	0.000207	0.00833	CcSEcCtD
Pralatrexate—Sepsis—Fluorouracil—stomach cancer	0.000201	0.00808	CcSEcCtD
Pralatrexate—Body temperature increased—Floxuridine—stomach cancer	0.0002	0.00805	CcSEcCtD
Pralatrexate—Abdominal pain—Floxuridine—stomach cancer	0.0002	0.00805	CcSEcCtD
Pralatrexate—Oedema—Mitomycin—stomach cancer	0.000198	0.00799	CcSEcCtD
Pralatrexate—Thrombocytopenia—Mitomycin—stomach cancer	0.000194	0.00782	CcSEcCtD
Pralatrexate—Anorexia—Mitomycin—stomach cancer	0.000189	0.00762	CcSEcCtD
Pralatrexate—Asthenia—Floxuridine—stomach cancer	0.000181	0.00731	CcSEcCtD
Pralatrexate—Dyspnoea—Mitomycin—stomach cancer	0.000177	0.00712	CcSEcCtD
Pralatrexate—Diarrhoea—Floxuridine—stomach cancer	0.000173	0.00697	CcSEcCtD
Pralatrexate—Decreased appetite—Mitomycin—stomach cancer	0.000172	0.00695	CcSEcCtD
Pralatrexate—Fatigue—Mitomycin—stomach cancer	0.000171	0.00689	CcSEcCtD
Pralatrexate—Dehydration—Irinotecan—stomach cancer	0.000163	0.00657	CcSEcCtD
Pralatrexate—Vomiting—Floxuridine—stomach cancer	0.000161	0.00648	CcSEcCtD
Pralatrexate—Hypokalaemia—Irinotecan—stomach cancer	0.000159	0.00643	CcSEcCtD
Pralatrexate—Rash—Floxuridine—stomach cancer	0.000159	0.00642	CcSEcCtD
Pralatrexate—Dermatitis—Floxuridine—stomach cancer	0.000159	0.00642	CcSEcCtD
Pralatrexate—Body temperature increased—Mitomycin—stomach cancer	0.000157	0.00632	CcSEcCtD
Pralatrexate—Nausea—Floxuridine—stomach cancer	0.00015	0.00605	CcSEcCtD
Pralatrexate—Sepsis—Docetaxel—stomach cancer	0.000145	0.00584	CcSEcCtD
Pralatrexate—Asthenia—Mitomycin—stomach cancer	0.000142	0.00573	CcSEcCtD
Pralatrexate—Neutropenia—Irinotecan—stomach cancer	0.000142	0.00571	CcSEcCtD
Pralatrexate—Folic Acid—MTHFR—stomach cancer	0.000141	0.101	CrCbGaD
Pralatrexate—Tetrahydrofolic acid—MTHFR—stomach cancer	0.000141	0.101	CrCbGaD
Pralatrexate—Upper respiratory tract infection—Irinotecan—stomach cancer	0.000141	0.00567	CcSEcCtD
Pralatrexate—Sepsis—Capecitabine—stomach cancer	0.00014	0.00565	CcSEcCtD
Pralatrexate—Pancytopenia—Fluorouracil—stomach cancer	0.000138	0.00555	CcSEcCtD
Pralatrexate—Diarrhoea—Mitomycin—stomach cancer	0.000136	0.00547	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.000135	0.00543	CcSEcCtD
Pralatrexate—Neoplasm malignant—Epirubicin—stomach cancer	0.000132	0.00531	CcSEcCtD
Pralatrexate—Vomiting—Mitomycin—stomach cancer	0.000126	0.00508	CcSEcCtD
Pralatrexate—Rash—Mitomycin—stomach cancer	0.000125	0.00504	CcSEcCtD
Pralatrexate—Dermatitis—Mitomycin—stomach cancer	0.000125	0.00503	CcSEcCtD
Pralatrexate—Epistaxis—Fluorouracil—stomach cancer	0.000122	0.00492	CcSEcCtD
Pralatrexate—Neoplasm malignant—Doxorubicin—stomach cancer	0.000122	0.00491	CcSEcCtD
Pralatrexate—Methotrexate—TYMS—stomach cancer	0.000121	0.0873	CrCbGaD
Pralatrexate—Pain in extremity—Docetaxel—stomach cancer	0.000121	0.00488	CcSEcCtD
Pralatrexate—Nausea—Mitomycin—stomach cancer	0.000118	0.00475	CcSEcCtD
Pralatrexate—Pain in extremity—Capecitabine—stomach cancer	0.000117	0.00473	CcSEcCtD
Pralatrexate—Dehydration—Docetaxel—stomach cancer	0.000113	0.00454	CcSEcCtD
Pralatrexate—Liver function test abnormal—Docetaxel—stomach cancer	0.000112	0.00451	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.000109	0.0044	CcSEcCtD
Pralatrexate—Dehydration—Capecitabine—stomach cancer	0.000109	0.0044	CcSEcCtD
Pralatrexate—Liver function test abnormal—Capecitabine—stomach cancer	0.000108	0.00436	CcSEcCtD
Pralatrexate—Hypokalaemia—Capecitabine—stomach cancer	0.000107	0.0043	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000106	0.00426	CcSEcCtD
Pralatrexate—Sepsis—Methotrexate—stomach cancer	0.000104	0.00421	CcSEcCtD
Pralatrexate—Back pain—Irinotecan—stomach cancer	0.000102	0.00411	CcSEcCtD
Pralatrexate—Pancytopenia—Docetaxel—stomach cancer	9.94e-05	0.00401	CcSEcCtD
Pralatrexate—Neutropenia—Docetaxel—stomach cancer	9.79e-05	0.00395	CcSEcCtD
Pralatrexate—Sepsis—Epirubicin—stomach cancer	9.77e-05	0.00394	CcSEcCtD
Pralatrexate—Anaemia—Irinotecan—stomach cancer	9.75e-05	0.00393	CcSEcCtD
Pralatrexate—Methotrexate—MTHFR—stomach cancer	9.65e-05	0.0694	CrCbGaD
Pralatrexate—Pancytopenia—Capecitabine—stomach cancer	9.63e-05	0.00388	CcSEcCtD
Pralatrexate—Neutropenia—Capecitabine—stomach cancer	9.48e-05	0.00382	CcSEcCtD
Pralatrexate—Leukopenia—Irinotecan—stomach cancer	9.45e-05	0.00381	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Capecitabine—stomach cancer	9.42e-05	0.0038	CcSEcCtD
Pralatrexate—Anaemia—Fluorouracil—stomach cancer	9.34e-05	0.00376	CcSEcCtD
Pralatrexate—Cough—Irinotecan—stomach cancer	9.21e-05	0.00371	CcSEcCtD
Pralatrexate—Leukopenia—Fluorouracil—stomach cancer	9.05e-05	0.00365	CcSEcCtD
Pralatrexate—Sepsis—Doxorubicin—stomach cancer	9.04e-05	0.00364	CcSEcCtD
Pralatrexate—Epistaxis—Docetaxel—stomach cancer	8.8e-05	0.00355	CcSEcCtD
Pralatrexate—Oedema—Irinotecan—stomach cancer	8.61e-05	0.00347	CcSEcCtD
Pralatrexate—Epistaxis—Capecitabine—stomach cancer	8.52e-05	0.00344	CcSEcCtD
Pralatrexate—Thrombocytopenia—Irinotecan—stomach cancer	8.43e-05	0.0034	CcSEcCtD
Pralatrexate—Oedema—Fluorouracil—stomach cancer	8.25e-05	0.00332	CcSEcCtD
Pralatrexate—Anorexia—Irinotecan—stomach cancer	8.21e-05	0.00331	CcSEcCtD
Pralatrexate—Pain in extremity—Epirubicin—stomach cancer	8.17e-05	0.00329	CcSEcCtD
Pralatrexate—Thrombocytopenia—Fluorouracil—stomach cancer	8.08e-05	0.00325	CcSEcCtD
Pralatrexate—Liver function test abnormal—Methotrexate—stomach cancer	8.06e-05	0.00325	CcSEcCtD
Pralatrexate—Tachycardia—Fluorouracil—stomach cancer	8.05e-05	0.00324	CcSEcCtD
Pralatrexate—Anorexia—Fluorouracil—stomach cancer	7.86e-05	0.00317	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Methotrexate—stomach cancer	7.86e-05	0.00317	CcSEcCtD
Pralatrexate—Dyspnoea—Irinotecan—stomach cancer	7.68e-05	0.00309	CcSEcCtD
Pralatrexate—Dehydration—Epirubicin—stomach cancer	7.6e-05	0.00306	CcSEcCtD
Pralatrexate—Pain in extremity—Doxorubicin—stomach cancer	7.56e-05	0.00305	CcSEcCtD
Pralatrexate—Liver function test abnormal—Epirubicin—stomach cancer	7.54e-05	0.00304	CcSEcCtD
Pralatrexate—Decreased appetite—Irinotecan—stomach cancer	7.49e-05	0.00302	CcSEcCtD
Pralatrexate—Hypokalaemia—Epirubicin—stomach cancer	7.44e-05	0.003	CcSEcCtD
Pralatrexate—Fatigue—Irinotecan—stomach cancer	7.42e-05	0.00299	CcSEcCtD
Pralatrexate—Constipation—Irinotecan—stomach cancer	7.36e-05	0.00297	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Epirubicin—stomach cancer	7.36e-05	0.00296	CcSEcCtD
Pralatrexate—Dyspnoea—Fluorouracil—stomach cancer	7.35e-05	0.00296	CcSEcCtD
Pralatrexate—Decreased appetite—Fluorouracil—stomach cancer	7.17e-05	0.00289	CcSEcCtD
Pralatrexate—Pancytopenia—Methotrexate—stomach cancer	7.17e-05	0.00289	CcSEcCtD
Pralatrexate—Back pain—Docetaxel—stomach cancer	7.06e-05	0.00284	CcSEcCtD
Pralatrexate—Neutropenia—Methotrexate—stomach cancer	7.06e-05	0.00284	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Irinotecan—stomach cancer	7.04e-05	0.00284	CcSEcCtD
Pralatrexate—Dehydration—Doxorubicin—stomach cancer	7.03e-05	0.00283	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Methotrexate—stomach cancer	7.01e-05	0.00283	CcSEcCtD
Pralatrexate—Liver function test abnormal—Doxorubicin—stomach cancer	6.98e-05	0.00281	CcSEcCtD
Pralatrexate—Hypokalaemia—Doxorubicin—stomach cancer	6.88e-05	0.00277	CcSEcCtD
Pralatrexate—Back pain—Capecitabine—stomach cancer	6.83e-05	0.00275	CcSEcCtD
Pralatrexate—Abdominal pain—Irinotecan—stomach cancer	6.81e-05	0.00274	CcSEcCtD
Pralatrexate—Body temperature increased—Irinotecan—stomach cancer	6.81e-05	0.00274	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	6.81e-05	0.00274	CcSEcCtD
Pralatrexate—Anaemia—Docetaxel—stomach cancer	6.74e-05	0.00272	CcSEcCtD
Pralatrexate—Pancytopenia—Epirubicin—stomach cancer	6.71e-05	0.0027	CcSEcCtD
Pralatrexate—Neutropenia—Epirubicin—stomach cancer	6.6e-05	0.00266	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Epirubicin—stomach cancer	6.56e-05	0.00264	CcSEcCtD
Pralatrexate—Leukopenia—Docetaxel—stomach cancer	6.53e-05	0.00263	CcSEcCtD
Pralatrexate—Anaemia—Capecitabine—stomach cancer	6.53e-05	0.00263	CcSEcCtD
Pralatrexate—Body temperature increased—Fluorouracil—stomach cancer	6.52e-05	0.00263	CcSEcCtD
Pralatrexate—Cough—Docetaxel—stomach cancer	6.37e-05	0.00257	CcSEcCtD
Pralatrexate—Epistaxis—Methotrexate—stomach cancer	6.35e-05	0.00256	CcSEcCtD
Pralatrexate—Leukopenia—Capecitabine—stomach cancer	6.32e-05	0.00255	CcSEcCtD
Pralatrexate—Pancytopenia—Doxorubicin—stomach cancer	6.2e-05	0.0025	CcSEcCtD
Pralatrexate—Asthenia—Irinotecan—stomach cancer	6.18e-05	0.00249	CcSEcCtD
Pralatrexate—Cough—Capecitabine—stomach cancer	6.16e-05	0.00248	CcSEcCtD
Pralatrexate—Neutropenia—Doxorubicin—stomach cancer	6.11e-05	0.00246	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Doxorubicin—stomach cancer	6.07e-05	0.00245	CcSEcCtD
Pralatrexate—Oedema—Docetaxel—stomach cancer	5.95e-05	0.0024	CcSEcCtD
Pralatrexate—Epistaxis—Epirubicin—stomach cancer	5.94e-05	0.00239	CcSEcCtD
Pralatrexate—Diarrhoea—Irinotecan—stomach cancer	5.89e-05	0.00237	CcSEcCtD
Pralatrexate—Pruritus—Fluorouracil—stomach cancer	5.84e-05	0.00235	CcSEcCtD
Pralatrexate—Thrombocytopenia—Docetaxel—stomach cancer	5.83e-05	0.00235	CcSEcCtD
Pralatrexate—Tachycardia—Docetaxel—stomach cancer	5.81e-05	0.00234	CcSEcCtD
Pralatrexate—Oedema—Capecitabine—stomach cancer	5.76e-05	0.00232	CcSEcCtD
Pralatrexate—Anorexia—Docetaxel—stomach cancer	5.67e-05	0.00229	CcSEcCtD
Pralatrexate—Diarrhoea—Fluorouracil—stomach cancer	5.64e-05	0.00227	CcSEcCtD
Pralatrexate—Thrombocytopenia—Capecitabine—stomach cancer	5.64e-05	0.00227	CcSEcCtD
Pralatrexate—Tachycardia—Capecitabine—stomach cancer	5.63e-05	0.00227	CcSEcCtD
Pralatrexate—Epistaxis—Doxorubicin—stomach cancer	5.49e-05	0.00221	CcSEcCtD
Pralatrexate—Anorexia—Capecitabine—stomach cancer	5.49e-05	0.00221	CcSEcCtD
Pralatrexate—Vomiting—Irinotecan—stomach cancer	5.48e-05	0.00221	CcSEcCtD
Pralatrexate—Rash—Irinotecan—stomach cancer	5.43e-05	0.00219	CcSEcCtD
Pralatrexate—Dermatitis—Irinotecan—stomach cancer	5.42e-05	0.00219	CcSEcCtD
Pralatrexate—Dyspnoea—Docetaxel—stomach cancer	5.31e-05	0.00214	CcSEcCtD
Pralatrexate—Vomiting—Fluorouracil—stomach cancer	5.24e-05	0.00211	CcSEcCtD
Pralatrexate—Rash—Fluorouracil—stomach cancer	5.2e-05	0.0021	CcSEcCtD
Pralatrexate—Dermatitis—Fluorouracil—stomach cancer	5.2e-05	0.00209	CcSEcCtD
Pralatrexate—Decreased appetite—Docetaxel—stomach cancer	5.18e-05	0.00209	CcSEcCtD
Pralatrexate—Dyspnoea—Capecitabine—stomach cancer	5.14e-05	0.00207	CcSEcCtD
Pralatrexate—Fatigue—Docetaxel—stomach cancer	5.13e-05	0.00207	CcSEcCtD
Pralatrexate—Nausea—Irinotecan—stomach cancer	5.12e-05	0.00206	CcSEcCtD
Pralatrexate—Constipation—Docetaxel—stomach cancer	5.09e-05	0.00205	CcSEcCtD
Pralatrexate—Back pain—Methotrexate—stomach cancer	5.09e-05	0.00205	CcSEcCtD
Pralatrexate—Decreased appetite—Capecitabine—stomach cancer	5.01e-05	0.00202	CcSEcCtD
Pralatrexate—Fatigue—Capecitabine—stomach cancer	4.97e-05	0.002	CcSEcCtD
Pralatrexate—Constipation—Capecitabine—stomach cancer	4.93e-05	0.00199	CcSEcCtD
Pralatrexate—Nausea—Fluorouracil—stomach cancer	4.9e-05	0.00197	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Docetaxel—stomach cancer	4.87e-05	0.00196	CcSEcCtD
Pralatrexate—Anaemia—Methotrexate—stomach cancer	4.86e-05	0.00196	CcSEcCtD
Pralatrexate—Back pain—Epirubicin—stomach cancer	4.76e-05	0.00192	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Capecitabine—stomach cancer	4.71e-05	0.0019	CcSEcCtD
Pralatrexate—Abdominal pain—Docetaxel—stomach cancer	4.71e-05	0.0019	CcSEcCtD
Pralatrexate—Body temperature increased—Docetaxel—stomach cancer	4.71e-05	0.0019	CcSEcCtD
Pralatrexate—Leukopenia—Methotrexate—stomach cancer	4.71e-05	0.0019	CcSEcCtD
Pralatrexate—Cough—Methotrexate—stomach cancer	4.59e-05	0.00185	CcSEcCtD
Pralatrexate—Abdominal pain—Capecitabine—stomach cancer	4.56e-05	0.00184	CcSEcCtD
Pralatrexate—Body temperature increased—Capecitabine—stomach cancer	4.56e-05	0.00184	CcSEcCtD
Pralatrexate—Anaemia—Epirubicin—stomach cancer	4.55e-05	0.00183	CcSEcCtD
Pralatrexate—Leukopenia—Epirubicin—stomach cancer	4.4e-05	0.00177	CcSEcCtD
Pralatrexate—Back pain—Doxorubicin—stomach cancer	4.4e-05	0.00177	CcSEcCtD
Pralatrexate—Cough—Epirubicin—stomach cancer	4.29e-05	0.00173	CcSEcCtD
Pralatrexate—Asthenia—Docetaxel—stomach cancer	4.27e-05	0.00172	CcSEcCtD
Pralatrexate—Pruritus—Docetaxel—stomach cancer	4.21e-05	0.0017	CcSEcCtD
Pralatrexate—Anaemia—Doxorubicin—stomach cancer	4.21e-05	0.0017	CcSEcCtD
Pralatrexate—Thrombocytopenia—Methotrexate—stomach cancer	4.2e-05	0.00169	CcSEcCtD
Pralatrexate—Asthenia—Capecitabine—stomach cancer	4.14e-05	0.00167	CcSEcCtD
Pralatrexate—Anorexia—Methotrexate—stomach cancer	4.09e-05	0.00165	CcSEcCtD
Pralatrexate—Pruritus—Capecitabine—stomach cancer	4.08e-05	0.00164	CcSEcCtD
Pralatrexate—Leukopenia—Doxorubicin—stomach cancer	4.07e-05	0.00164	CcSEcCtD
Pralatrexate—Diarrhoea—Docetaxel—stomach cancer	4.07e-05	0.00164	CcSEcCtD
Pralatrexate—Oedema—Epirubicin—stomach cancer	4.02e-05	0.00162	CcSEcCtD
Pralatrexate—Cough—Doxorubicin—stomach cancer	3.97e-05	0.0016	CcSEcCtD
Pralatrexate—Diarrhoea—Capecitabine—stomach cancer	3.94e-05	0.00159	CcSEcCtD
Pralatrexate—Thrombocytopenia—Epirubicin—stomach cancer	3.93e-05	0.00158	CcSEcCtD
Pralatrexate—Tachycardia—Epirubicin—stomach cancer	3.92e-05	0.00158	CcSEcCtD
Pralatrexate—Anorexia—Epirubicin—stomach cancer	3.83e-05	0.00154	CcSEcCtD
Pralatrexate—Dyspnoea—Methotrexate—stomach cancer	3.83e-05	0.00154	CcSEcCtD
Pralatrexate—Vomiting—Docetaxel—stomach cancer	3.79e-05	0.00153	CcSEcCtD
Pralatrexate—Rash—Docetaxel—stomach cancer	3.75e-05	0.00151	CcSEcCtD
Pralatrexate—Dermatitis—Docetaxel—stomach cancer	3.75e-05	0.00151	CcSEcCtD
Pralatrexate—Decreased appetite—Methotrexate—stomach cancer	3.73e-05	0.0015	CcSEcCtD
Pralatrexate—Oedema—Doxorubicin—stomach cancer	3.72e-05	0.0015	CcSEcCtD
Pralatrexate—Fatigue—Methotrexate—stomach cancer	3.7e-05	0.00149	CcSEcCtD
Pralatrexate—Vomiting—Capecitabine—stomach cancer	3.66e-05	0.00148	CcSEcCtD
Pralatrexate—Thrombocytopenia—Doxorubicin—stomach cancer	3.64e-05	0.00147	CcSEcCtD
Pralatrexate—Rash—Capecitabine—stomach cancer	3.63e-05	0.00146	CcSEcCtD
Pralatrexate—Dermatitis—Capecitabine—stomach cancer	3.63e-05	0.00146	CcSEcCtD
Pralatrexate—Tachycardia—Doxorubicin—stomach cancer	3.63e-05	0.00146	CcSEcCtD
Pralatrexate—Dyspnoea—Epirubicin—stomach cancer	3.58e-05	0.00144	CcSEcCtD
Pralatrexate—Anorexia—Doxorubicin—stomach cancer	3.54e-05	0.00143	CcSEcCtD
Pralatrexate—Nausea—Docetaxel—stomach cancer	3.54e-05	0.00143	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Methotrexate—stomach cancer	3.51e-05	0.00141	CcSEcCtD
Pralatrexate—Decreased appetite—Epirubicin—stomach cancer	3.49e-05	0.00141	CcSEcCtD
Pralatrexate—Fatigue—Epirubicin—stomach cancer	3.46e-05	0.0014	CcSEcCtD
Pralatrexate—Constipation—Epirubicin—stomach cancer	3.43e-05	0.00138	CcSEcCtD
Pralatrexate—Nausea—Capecitabine—stomach cancer	3.42e-05	0.00138	CcSEcCtD
Pralatrexate—Abdominal pain—Methotrexate—stomach cancer	3.39e-05	0.00137	CcSEcCtD
Pralatrexate—Body temperature increased—Methotrexate—stomach cancer	3.39e-05	0.00137	CcSEcCtD
Pralatrexate—Dyspnoea—Doxorubicin—stomach cancer	3.31e-05	0.00133	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Epirubicin—stomach cancer	3.28e-05	0.00132	CcSEcCtD
Pralatrexate—Decreased appetite—Doxorubicin—stomach cancer	3.23e-05	0.0013	CcSEcCtD
Pralatrexate—Methotrexate—ALB—stomach cancer	3.22e-05	0.0232	CrCbGaD
Pralatrexate—Fatigue—Doxorubicin—stomach cancer	3.2e-05	0.00129	CcSEcCtD
Pralatrexate—Constipation—Doxorubicin—stomach cancer	3.18e-05	0.00128	CcSEcCtD
Pralatrexate—Abdominal pain—Epirubicin—stomach cancer	3.17e-05	0.00128	CcSEcCtD
Pralatrexate—Body temperature increased—Epirubicin—stomach cancer	3.17e-05	0.00128	CcSEcCtD
Pralatrexate—Asthenia—Methotrexate—stomach cancer	3.08e-05	0.00124	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Doxorubicin—stomach cancer	3.04e-05	0.00122	CcSEcCtD
Pralatrexate—Pruritus—Methotrexate—stomach cancer	3.04e-05	0.00122	CcSEcCtD
Pralatrexate—Body temperature increased—Doxorubicin—stomach cancer	2.94e-05	0.00118	CcSEcCtD
Pralatrexate—Abdominal pain—Doxorubicin—stomach cancer	2.94e-05	0.00118	CcSEcCtD
Pralatrexate—Diarrhoea—Methotrexate—stomach cancer	2.94e-05	0.00118	CcSEcCtD
Pralatrexate—Asthenia—Epirubicin—stomach cancer	2.88e-05	0.00116	CcSEcCtD
Pralatrexate—Pruritus—Epirubicin—stomach cancer	2.84e-05	0.00114	CcSEcCtD
Pralatrexate—Diarrhoea—Epirubicin—stomach cancer	2.75e-05	0.00111	CcSEcCtD
Pralatrexate—Vomiting—Methotrexate—stomach cancer	2.73e-05	0.0011	CcSEcCtD
Pralatrexate—Rash—Methotrexate—stomach cancer	2.71e-05	0.00109	CcSEcCtD
Pralatrexate—Dermatitis—Methotrexate—stomach cancer	2.7e-05	0.00109	CcSEcCtD
Pralatrexate—Asthenia—Doxorubicin—stomach cancer	2.67e-05	0.00107	CcSEcCtD
Pralatrexate—Pruritus—Doxorubicin—stomach cancer	2.63e-05	0.00106	CcSEcCtD
Pralatrexate—Vomiting—Epirubicin—stomach cancer	2.55e-05	0.00103	CcSEcCtD
Pralatrexate—Nausea—Methotrexate—stomach cancer	2.55e-05	0.00103	CcSEcCtD
Pralatrexate—Diarrhoea—Doxorubicin—stomach cancer	2.54e-05	0.00102	CcSEcCtD
Pralatrexate—Rash—Epirubicin—stomach cancer	2.53e-05	0.00102	CcSEcCtD
Pralatrexate—Dermatitis—Epirubicin—stomach cancer	2.53e-05	0.00102	CcSEcCtD
Pralatrexate—Nausea—Epirubicin—stomach cancer	2.39e-05	0.000961	CcSEcCtD
Pralatrexate—Vomiting—Doxorubicin—stomach cancer	2.36e-05	0.000952	CcSEcCtD
Pralatrexate—Rash—Doxorubicin—stomach cancer	2.34e-05	0.000944	CcSEcCtD
Pralatrexate—Dermatitis—Doxorubicin—stomach cancer	2.34e-05	0.000943	CcSEcCtD
Pralatrexate—Nausea—Doxorubicin—stomach cancer	2.21e-05	0.000889	CcSEcCtD
Pralatrexate—FPGS—Disease—FYN—stomach cancer	1.74e-05	0.000533	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—APEX1—stomach cancer	1.72e-05	0.000528	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—FBP1—stomach cancer	1.7e-05	0.000522	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA1—stomach cancer	1.7e-05	0.000522	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CKB—stomach cancer	1.7e-05	0.000522	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NDUFA2—stomach cancer	1.7e-05	0.000522	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CAV1—stomach cancer	1.7e-05	0.000522	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—APOA1—stomach cancer	1.7e-05	0.000521	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	1.68e-05	0.000516	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ERCC2—stomach cancer	1.67e-05	0.000512	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALDH7A1—stomach cancer	1.66e-05	0.000509	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PLCE1—stomach cancer	1.66e-05	0.000509	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PPP2R1A—stomach cancer	1.65e-05	0.000506	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ERCC2—stomach cancer	1.64e-05	0.000504	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	1.64e-05	0.000504	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—TYMS—stomach cancer	1.64e-05	0.000502	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FGFR2—stomach cancer	1.63e-05	0.0005	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTP1—stomach cancer	1.62e-05	0.000496	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6ST—stomach cancer	1.61e-05	0.000495	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PPP2R1A—stomach cancer	1.6e-05	0.000492	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PLIN2—stomach cancer	1.6e-05	0.000491	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—HMOX1—stomach cancer	1.6e-05	0.00049	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—UMPS—stomach cancer	1.59e-05	0.000488	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CHEK2—stomach cancer	1.58e-05	0.000486	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—MYC—stomach cancer	1.57e-05	0.000482	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTHFR—stomach cancer	1.57e-05	0.000481	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PPP2R1A—stomach cancer	1.57e-05	0.00048	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA2—stomach cancer	1.56e-05	0.000478	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	1.56e-05	0.000477	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—APC—stomach cancer	1.55e-05	0.000476	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—MTHFR—stomach cancer	1.55e-05	0.000474	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—APEX1—stomach cancer	1.54e-05	0.000472	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PGAM1—stomach cancer	1.52e-05	0.000466	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NT5E—stomach cancer	1.52e-05	0.000466	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—TYMS—stomach cancer	1.5e-05	0.000462	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IRS2—stomach cancer	1.49e-05	0.000458	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTM1—stomach cancer	1.49e-05	0.000456	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.48e-05	0.000455	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.48e-05	0.000454	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PDHA1—stomach cancer	1.48e-05	0.000454	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ECHS1—stomach cancer	1.48e-05	0.000454	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—BIRC5—stomach cancer	1.47e-05	0.000451	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TYMS—stomach cancer	1.46e-05	0.000449	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PLCE1—stomach cancer	1.45e-05	0.000444	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALDH7A1—stomach cancer	1.45e-05	0.000444	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CAV1—stomach cancer	1.45e-05	0.000444	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APOA1—stomach cancer	1.44e-05	0.000443	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6R—stomach cancer	1.44e-05	0.000442	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ALDOB—stomach cancer	1.44e-05	0.000442	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.44e-05	0.000441	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CAV1—stomach cancer	1.43e-05	0.000437	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—APOA1—stomach cancer	1.42e-05	0.000436	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—JUN—stomach cancer	1.42e-05	0.000436	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RPL15—stomach cancer	1.41e-05	0.000433	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.4e-05	0.00043	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PPP2R1A—stomach cancer	1.4e-05	0.000429	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ERCC2—stomach cancer	1.4e-05	0.000429	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—TYMP—stomach cancer	1.39e-05	0.000427	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—FADS1—stomach cancer	1.39e-05	0.000427	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—UMPS—stomach cancer	1.39e-05	0.000426	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NPM1—stomach cancer	1.39e-05	0.000425	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6ST—stomach cancer	1.37e-05	0.000421	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SERPINE1—stomach cancer	1.35e-05	0.000414	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—MAPK8—stomach cancer	1.35e-05	0.000413	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RBP4—stomach cancer	1.34e-05	0.000411	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APC—stomach cancer	1.32e-05	0.000404	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RPS26—stomach cancer	1.32e-05	0.000404	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—BIRC5—stomach cancer	1.32e-05	0.000404	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—MTHFR—stomach cancer	1.31e-05	0.000403	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PPIA—stomach cancer	1.31e-05	0.000401	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SREBF2—stomach cancer	1.3e-05	0.000399	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—RHOA—stomach cancer	1.3e-05	0.000399	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.29e-05	0.000397	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PDHA1—stomach cancer	1.29e-05	0.000396	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ECHS1—stomach cancer	1.29e-05	0.000396	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS3—stomach cancer	1.29e-05	0.000395	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—RORA—stomach cancer	1.29e-05	0.000395	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—BIRC5—stomach cancer	1.28e-05	0.000394	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDK4—stomach cancer	1.28e-05	0.000391	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—PRKCB—stomach cancer	1.25e-05	0.000385	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PPARG—stomach cancer	1.25e-05	0.000384	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.22e-05	0.000376	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6R—stomach cancer	1.22e-05	0.000376	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—TYMP—stomach cancer	1.21e-05	0.000372	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—FADS1—stomach cancer	1.21e-05	0.000372	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CAV1—stomach cancer	1.21e-05	0.000372	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—APOA1—stomach cancer	1.21e-05	0.000371	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALDOB—stomach cancer	1.21e-05	0.00037	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ERBB2—stomach cancer	1.2e-05	0.000369	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.19e-05	0.000365	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—stomach cancer	1.18e-05	0.000361	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.16e-05	0.000357	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.16e-05	0.000357	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—BIRC5—stomach cancer	1.15e-05	0.000352	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SERPINE1—stomach cancer	1.15e-05	0.000352	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDK4—stomach cancer	1.14e-05	0.00035	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SREBF2—stomach cancer	1.14e-05	0.000349	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ALB—stomach cancer	1.13e-05	0.000346	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—RORA—stomach cancer	1.12e-05	0.000344	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PRKCB—stomach cancer	1.12e-05	0.000344	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALOX5—stomach cancer	1.12e-05	0.000344	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RPS19—stomach cancer	1.12e-05	0.000343	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKR1C3—stomach cancer	1.12e-05	0.000343	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1B—stomach cancer	1.11e-05	0.000342	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDK4—stomach cancer	1.11e-05	0.000341	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.11e-05	0.00034	CbGpPWpGaD
Pralatrexate—FPGS—Disease—RHOA—stomach cancer	1.11e-05	0.000339	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—DPYD—stomach cancer	1.1e-05	0.000338	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.1e-05	0.000338	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PRKCB—stomach cancer	1.09e-05	0.000336	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS3—stomach cancer	1.09e-05	0.000336	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ENO1—stomach cancer	1.09e-05	0.000335	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—NOS3—stomach cancer	1.08e-05	0.000331	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PPARG—stomach cancer	1.07e-05	0.000327	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALDOB—stomach cancer	1.05e-05	0.000323	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1A—stomach cancer	1.03e-05	0.000316	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ERBB2—stomach cancer	1.02e-05	0.000314	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.01e-05	0.00031	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—stomach cancer	1e-05	0.000307	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK4—stomach cancer	9.95e-06	0.000305	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RPS6—stomach cancer	9.9e-06	0.000304	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—stomach cancer	9.86e-06	0.000302	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PRKCB—stomach cancer	9.79e-06	0.0003	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALOX5—stomach cancer	9.78e-06	0.0003	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	9.78e-06	0.0003	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTT1—stomach cancer	9.75e-06	0.000299	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—stomach cancer	9.75e-06	0.000299	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD44—stomach cancer	9.68e-06	0.000297	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2A6—stomach cancer	9.64e-06	0.000296	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—DPYD—stomach cancer	9.62e-06	0.000295	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—stomach cancer	9.58e-06	0.000294	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1B—stomach cancer	9.48e-06	0.000291	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—stomach cancer	9.39e-06	0.000288	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKR1C3—stomach cancer	9.38e-06	0.000288	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—STAT3—stomach cancer	9.18e-06	0.000282	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—NOS3—stomach cancer	9.17e-06	0.000281	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ENO1—stomach cancer	9.14e-06	0.00028	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HBEGF—stomach cancer	9.1e-06	0.000279	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAPK3—stomach cancer	8.77e-06	0.000269	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1A—stomach cancer	8.75e-06	0.000268	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—stomach cancer	8.72e-06	0.000267	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—stomach cancer	8.63e-06	0.000265	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—stomach cancer	8.59e-06	0.000264	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MYC—stomach cancer	8.53e-06	0.000262	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTT1—stomach cancer	8.51e-06	0.000261	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—stomach cancer	8.51e-06	0.000261	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2A6—stomach cancer	8.41e-06	0.000258	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—stomach cancer	8.38e-06	0.000257	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAPK1—stomach cancer	8.35e-06	0.000256	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—stomach cancer	8.34e-06	0.000256	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND1—stomach cancer	8.24e-06	0.000253	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PPP2R1A—stomach cancer	8.23e-06	0.000252	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKR1C3—stomach cancer	8.18e-06	0.000251	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CD44—stomach cancer	8.1e-06	0.000249	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ENO1—stomach cancer	7.97e-06	0.000245	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—stomach cancer	7.97e-06	0.000244	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—KRAS—stomach cancer	7.88e-06	0.000242	CbGpPWpGaD
Pralatrexate—FPGS—Disease—STAT3—stomach cancer	7.81e-06	0.00024	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1B—stomach cancer	7.72e-06	0.000237	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SMAD4—stomach cancer	7.64e-06	0.000234	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—stomach cancer	7.61e-06	0.000233	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—stomach cancer	7.53e-06	0.000231	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAPK3—stomach cancer	7.46e-06	0.000229	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND1—stomach cancer	7.36e-06	0.000226	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MYC—stomach cancer	7.25e-06	0.000223	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FYN—stomach cancer	7.25e-06	0.000223	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CA—stomach cancer	7.24e-06	0.000222	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND1—stomach cancer	7.19e-06	0.00022	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1A—stomach cancer	7.12e-06	0.000219	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAPK1—stomach cancer	7.1e-06	0.000218	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—stomach cancer	7.1e-06	0.000218	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CD44—stomach cancer	7.07e-06	0.000217	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERCC2—stomach cancer	6.97e-06	0.000214	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—stomach cancer	6.95e-06	0.000213	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPP2R1A—stomach cancer	6.89e-06	0.000211	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGFR2—stomach cancer	6.81e-06	0.000209	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MAPK3—stomach cancer	6.79e-06	0.000208	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTP1—stomach cancer	6.76e-06	0.000207	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1B—stomach cancer	6.74e-06	0.000207	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KRAS—stomach cancer	6.7e-06	0.000206	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HRAS—stomach cancer	6.7e-06	0.000206	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HMOX1—stomach cancer	6.67e-06	0.000205	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYC—stomach cancer	6.61e-06	0.000203	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTHFR—stomach cancer	6.55e-06	0.000201	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MAPK1—stomach cancer	6.46e-06	0.000198	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND1—stomach cancer	6.43e-06	0.000197	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—stomach cancer	6.41e-06	0.000197	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—TYMS—stomach cancer	6.28e-06	0.000193	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IRS2—stomach cancer	6.24e-06	0.000191	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1A—stomach cancer	6.22e-06	0.000191	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTM1—stomach cancer	6.21e-06	0.000191	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CA—stomach cancer	6.16e-06	0.000189	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MAPK3—stomach cancer	6.07e-06	0.000186	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CA—stomach cancer	6.07e-06	0.000186	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CAV1—stomach cancer	6.05e-06	0.000185	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOA1—stomach cancer	6.03e-06	0.000185	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPP2R1A—stomach cancer	6.01e-06	0.000184	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MAPK3—stomach cancer	5.93e-06	0.000182	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYC—stomach cancer	5.91e-06	0.000181	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTP1—stomach cancer	5.9e-06	0.000181	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ERCC2—stomach cancer	5.84e-06	0.000179	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HMOX1—stomach cancer	5.82e-06	0.000178	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MAPK1—stomach cancer	5.78e-06	0.000177	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYC—stomach cancer	5.76e-06	0.000177	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6ST—stomach cancer	5.73e-06	0.000176	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HRAS—stomach cancer	5.7e-06	0.000175	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MAPK1—stomach cancer	5.64e-06	0.000173	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APC—stomach cancer	5.51e-06	0.000169	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTHFR—stomach cancer	5.49e-06	0.000168	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—stomach cancer	5.45e-06	0.000167	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTM1—stomach cancer	5.42e-06	0.000166	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MAPK3—stomach cancer	5.3e-06	0.000163	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CA—stomach cancer	5.16e-06	0.000158	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYC—stomach cancer	5.15e-06	0.000158	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6R—stomach cancer	5.11e-06	0.000157	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ERCC2—stomach cancer	5.1e-06	0.000156	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CAV1—stomach cancer	5.06e-06	0.000155	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—APOA1—stomach cancer	5.05e-06	0.000155	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MAPK1—stomach cancer	5.04e-06	0.000155	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—stomach cancer	4.85e-06	0.000149	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTHFR—stomach cancer	4.79e-06	0.000147	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SERPINE1—stomach cancer	4.79e-06	0.000147	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RHOA—stomach cancer	4.62e-06	0.000142	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS3—stomach cancer	4.57e-06	0.00014	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPARG—stomach cancer	4.45e-06	0.000137	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CAV1—stomach cancer	4.42e-06	0.000136	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APOA1—stomach cancer	4.41e-06	0.000135	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB2—stomach cancer	4.28e-06	0.000131	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—stomach cancer	4.23e-06	0.00013	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—stomach cancer	4.18e-06	0.000128	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—stomach cancer	4e-06	0.000123	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1B—stomach cancer	3.96e-06	0.000121	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPARG—stomach cancer	3.88e-06	0.000119	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NOS3—stomach cancer	3.83e-06	0.000117	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1A—stomach cancer	3.65e-06	0.000112	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—stomach cancer	3.5e-06	0.000107	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—stomach cancer	3.49e-06	0.000107	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NOS3—stomach cancer	3.34e-06	0.000102	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT3—stomach cancer	3.26e-06	0.0001	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAPK3—stomach cancer	3.12e-06	9.56e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—stomach cancer	3.06e-06	9.37e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MYC—stomach cancer	3.03e-06	9.3e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAPK1—stomach cancer	2.96e-06	9.1e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—stomach cancer	2.96e-06	9.09e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KRAS—stomach cancer	2.8e-06	8.59e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CA—stomach cancer	2.57e-06	7.89e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HRAS—stomach cancer	2.38e-06	7.3e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—stomach cancer	2.28e-06	6.99e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CA—stomach cancer	2.15e-06	6.61e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CA—stomach cancer	1.88e-06	5.77e-05	CbGpPWpGaD
